Who is sponsoring NCT05272787?

NCT05272787 is sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

What drugs are being tested in NCT05272787?

Interventions in NCT05272787: TH Facial Moisturizer, TH Lip Moisturizer, Facial Moisturizer B (Control), Sunscreen, Facial wash.

Is NCT05272787 still recruiting?

NCT05272787 is currently completed. Last updated 29 June 2023.

Last reviewed 2023-06-29 · How we verify

NCT05272787

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 Laser

Completed NA Last updated 29 June 2023

What this trial tests

NA trial testing TH Facial Moisturizer in Skin Regeneration After Dermatological Facial Procedure With Fractional CO2 Laser in 35 participants. Completed in 16 June 2022.

Timeline

10 March 2022

Primary endpoint
13 April 2022

16 June 2022

Quick facts

Lead sponsor	Johnson & Johnson Consumer Inc. (J&JCI)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	35
Start date	10 March 2022
Primary completion	13 April 2022
Estimated completion	16 June 2022
Sites	1 location across Brazil

Drugs / interventions tested

TH Facial Moisturizer
TH Lip Moisturizer
Facial Moisturizer B (Control)
Sunscreen — full drug profile →
Facial wash

Conditions studied

Skin Regeneration After Dermatological Facial Procedure With Fractional CO2 Laser — all drugs for Skin Regeneration After Dermatological Facial Procedure With Fractional CO2 Laser →

Sponsor

Johnson & Johnson Consumer Inc. (J&JCI) — full company profile →

Who can join

Adults 18 to 65, any sex, with Skin Regeneration After Dermatological Facial Procedure With Fractional CO2 Laser. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is study aims to evaluate the topical safety (tolerability/acceptability) and efficacy of TH Facial Moisturizer and TH Lip Moisturizer Investigational products after 21 ± 2 days of use under normal conditions on the half-face by adult participants who underwent dermatological facial procedure with fractional CO2 Laser under the supervision of a dermatologist. For these investigational products, safety parameters, clinical efficacy, instrumental efficacy (skin hydration, skin barrier integrity and facial imaging) and perceived efficacy through subjective perception questionnaires will be evaluated. Subjects will receive the product to use it at home for 21 +/- 2 days.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other Johnson & Johnson Consumer Inc. (J&JCI) trials

Trials by the same sponsor.

NCT06852742 — A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin · NA · completed
NCT06734299 — A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones · NA · completed
NCT06658847 — A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Us · NA · completed
NCT06654102 — A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure · NA · completed
NCT06318637 — Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05272787 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Consumer Inc. (J&JCI)
Last refreshed: 29 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing